Combating Neuroinflammation By Improving Intracellular Brain Drug Delivery - Focus On L-Type Amino Acid Transporter 1
Year: 2023
Type: dissertation
Abstract: Neurodegenerative diseases (NDs) are a global health burden due to ageing populations.Tackling the associated neuroinflammation is a growing strategy to combat these NDs.One challenge in treating neuroinflammation is the restrictive permeation of neurotherapeutics across the blood-brain barrier (BBB).While the BBB protects brain tissues from foreign substances, most clinically used drugs are unable to pass this barrier and reach the brain in therapeutic doses.Membrane transportermediated delivery is one promising and feasible approach to safely improving drug delivery across the BBB and into brain cells.In this thesis, L-type amino acid transporter 1 (LAT1)-mediated transport of selected antiinflammatory prodrugs was used to examine the effects of improved brain drug delivery on neuroinflammation.First, LAT1-utilising prodrugs of ferulic acid (FA) and several non-steroidal anti-inflammatory drugs (NSAIDs) were examined for their improved delivery into human and mouse brain cells (i.e., astrocytes and microglia).Secondly, the distribution of LAT1utilising NSAIDs prodrugs to the brain was studied in mice.Lastly, the effects of improved brain delivery of LAT1-prodrug of salicylic acid (SA) were investigated in a lipopolysaccharide (LPS)-induced inflammation model in mice by following behavioural and brain proteome changes.
Author: Montaser, Ahmed
Institution: University of Eastern Finland
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7215145273
